Test - 86k

The chart shows the growth of an initial investment of $10,000 in Test - 86k, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Oct 1, 2020, Test - 86k's average daily return is +0.19%, while the average monthly return is +3.87%. At this rate, your investment would double in approximately 1.5 years.

Historically, 61% of months were positive and 39% were negative. The best month was May 2023 with a return of +30.5%, while the worst month was Apr 2022 at -24.0%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 3 months.

On a daily basis, Test - 86k closed higher 55% of trading days. The best single day was Apr 9, 2025 with a return of +15.1%, while the worst single day was Jan 27, 2025 at -10.2%.

Test - 86k has an annualized alpha of 26.43%, beta of 1.74, and R² of 0.62 versus S&P 500 Index. Calculated based on daily prices since October 01, 2020.

• This portfolio captured 266.56% of S&P 500 Index gains and 110.75% of its losses — amplifying both gains and losses, but participating more in upside than downside.
• This portfolio generated an annualized alpha of 26.43% versus S&P 500 Index — delivering returns beyond what market exposure alone would predict.
• Beta of 1.74 means this portfolio moves significantly more than S&P 500 Index — expect amplified gains in rallies and amplified losses in downturns.

Test - 86k has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

Test - 86k ranks 74 for risk / return — better than 74% of portfolios on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Test - 86k Sharpe ratios as of Apr 3, 2026 (values are recalculated daily):

• 1-Year: 1.73
• 5-Year: 1.28
• All Time: 1.34

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 0.98 to 1.66, this portfolio's current Sharpe ratio is in the top 25%. This signifies superior risk-adjusted performance, meaning the portfolio is delivering strong returns for the level of risk taken compared to most others.

The chart below shows the rolling Sharpe ratio of Test - 86k compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

Test - 86k provided a 0.25% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Test - 86k. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Test - 86k was 54.73%, occurring on Oct 14, 2022. Recovery took 153 trading sessions.

The current Test - 86k drawdown is 14.79%.

The chart below shows the rolling one-month volatility.